PRODUCTS CONTACT COMPANY EVENTS ACADEMY NEWS Next Generation Flow Solutions Home/Next Generation Flow Solutions What’s Next Generation Flow™? Next Generation Flow™ (NGF) is based on the standardization of every step of the process from sample preparation to expert-guided automated reporting. Cytognos, in collaboration with EuroFlow™, offers a complete and scientific-based solution to cover all the needs of a clinical laboratory, including the support of our highly specialized technical team: Setting up and technical implementation of the EuroFlow™ SOPs. Staining of samples using the NGF product line. Acquisition of samples in compatible cytometers (e.g. Omnicyt™). Automated data analysis and reporting using Infinicyt™. Next Generation Flow™ has emerged in recent years as a solution to overcome the limitations of 1st generation (conventional) flow cytometry and also, as a complement to genetic and imaging methodologies. DOWNLOAD EUROFLOW WORKFLOW POSTER DOWNLOAD EUROFLOW PID WORKFLOW POSTER What are the advantages of Next Generation Flow™? Objective expert-based panel design Fully standardized methodology High reproducibility between centers High sensitivity Complete quality assessment programs available Objective and guided data analysis The EuroFlow™ NGF panels were developed in different centers taking into account the availability of specific antibody clones and fluorochrome conjugates, literature and the experience and knowledge of all the centers involved. Several rounds of validation, using unbiased software algorithms, were performed to obtain the most efficient combination per disease category. A strong technical support team with the scientific-based knowledge and practical experience to implement Next Generation Flow™ WHAT IS THE NEXT GENERATION FLOW™ WORKFLOW? WHO CONTRIBUTED TO THE DEVELOPMENT OF THE NGF? HOW CAN THE NGF METHODOLOGY BE IMPLEMENTED? WHO CAN BENEFIT FROM CYTOGNOS NGF SOLUTION? HOW DOES CYTOGNOS CONTRIBUTE TO THE IMPLEMENTATION OF THE NGF? What are the characteristics of NGF? Standard Efficient Reproducible Sensitive The laboratory workflow is standardized from sample preparation to data analysis as published in consensus guidelines by the EuroFlow™ consortium: www.euroflow.org. Validated SOPs are available as part of the EuroFlow™ NGF solution so no extra in-home validation needed. External validation available through the EuroFlow™ QA program. Next Generation Flow™ solution for Oncohematology Next Generation Flow™ solution for Immunology Next Generation Flow™ solution for Clinical trials Request a meeting with our technical team Name* Email address* Institution* Country... Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua And Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia And Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, The Democratic Republic Of The Cook Islands Costa Rica Cote D'Ivoire Croatia (Local Name: Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France France, Metropolitan French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard And Mc Donald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran (Islamic Republic Of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic Of Korea, Republic Of Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macau Macedonia, Former Yugoslav Republic Of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States Of Moldova, Republic Of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts And Nevis Saint Lucia Saint Vincent And The Grenadines Samoa San Marino Sao Tome And Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia South Africa South Georgia, South Sandwich Islands Spain Sri Lanka St. Helena St. Pierre And Miquelon Sudan Suriname Svalbard And Jan Mayen Islands Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic Of Thailand Togo Tokelau Tonga Trinidad And Tobago Tunisia Turkey Turkmenistan Turks And Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (British) Virgin Islands (U.S.) Wallis And Futuna Islands Western Sahara Yemen Yugoslavia Zambia Zimbabwe What is the nature of your enquiry? Request additional information I would like to implement the Next Generation Flow™ solution Arrange a meeting with the Technical Support team Others Privacy Policy* Accept the Cytognos, S.L. Privacy Policy Go to Privacy Policy and Summary of the use of your data. Send This field should be left blank Our products Next Generation Flow Solutions Acute Leukemia Chronic Lymphoproliferative Disorders Plasma Cell Dyscrasias Primary Immunodeficiencies Omnicyt™ Infinicyt™ The company About us Contact & Support Events Work with us Projects Subscribe to Newsletter Useful information EuroFlow™ Cytognos technology Minimal Residual Disease Clinical trials Scheduled webinars FAQs Legal Notice Legal Notice Terms of use Privacy Policy Cookie Policy Terms and Conditions of Sale Anti-corruption Policy License Agreement Cytognos, S.L. complies with ISO 9001:2015 Quality Management and ISO 13485:2016 for the design, development, production and sale of antibodies and flow cytometry kits for In Vitro products and research. Cytognos, S.L. products for In Vitro Diagnostic comply with Directive 98/79/EC. Copyright © 2021 Cytognos S.L.. All Rights Reserved. All products listed are labeled with some regulatory status as per indicated below: “RUO” or “For Research Use Only”: not intended for diagnostic or therapeutic procedures. “CE-IVD”: products intended for in vitro diagnostic use and conforming to European Directive (98/79/EC). “LUO” or “Laboratory Use Only”: general purpose laboratory reagents. “ASR” or “Analyte Specific Reagent”: reagents in which the analytical and performance characteristics are not established. ASRs are regulated by the US Food and Drug Administration (FDA). Cookies We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete, please read more. Accept Read more Change Settings